Screener
LeonaBio, Inc. LONA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by LeonaBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: LeonaBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211898
FAQ
- What is LeonaBio, Inc.'s EPS (diluted)?
- LeonaBio, Inc. (LONA) reported EPS (diluted) of -$1.73 in Q1 2026.
- How has LeonaBio, Inc.'s EPS (diluted) changed year-over-year?
- LeonaBio, Inc.'s EPS (diluted) increased by 26.1% year-over-year, from -$2.34 to -$1.73.
- What is the long-term trend for LeonaBio, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), LeonaBio, Inc.'s EPS (diluted) has grown at a 98.4% compound annual growth rate (CAGR), from -$1.49 to -$23.10.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about LeonaBio, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude